Accelerated wound healing phenotype in Interleukin 12/23 deficient mice

Journal of Inflammation

Volumn 8, Issue , 2011, Pages

  Matias, Marie A T ^a,b   Saunus, Jodi M ^b   Ivanovski, Saso ^c   Walsh, Laurence J ^a   Farah, Camile S ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

Angiogenesis; Inflammation; Interleukin 12; Interleukin 23; p40; Wound healing

Indexed keywords

CD31 ANTIGEN; CXCL2 CHEMOKINE; CYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 12; INTERLEUKIN 12 INTERLEUKIN 23P40; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 23P40; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MOUSE; MOUTH LESION; NONHUMAN; RNA ANALYSIS; WILD TYPE; WOUND CLOSURE; WOUND HEALING;

MUS;

EID: 83655183185     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-8-3922185520     Document Type: Article

References (56)

1. Nwomeh BC, Liang HX, Cohen IK, Yager DR: MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res 1999, 81:189-195. (Pubitemid 29397810)
2. Mast BA, Diegelmann RF, Krummel TM, Cohen IK: Scarless wound healing in the mammalian fetus. Surg Gynecol Obstet 1992, 174:441-451.
3. Martin P, D'Souza D, Martin J, Grose R, Cooper L, Maki R, McKercher SR: Wound healing in the PU.1 null mouse-tissue repair is not dependent on inflammatory cells. Curr Biol 2003, 13:1122-1128. (Pubitemid 36815260)
4. Cooper L, Johnson C, Burslem F, Martin P, Cooper L, Johnson C, Burslem F, Martin P: Wound healing and inflammation genes revealed by array analysis of 'macrophageless' PU.1 null mice. Genome Biol 2005, 6:R5.
5. Gallucci RM, Simeonova PP, Matheson JM, Kommineni C, Guriel JL, Sugawara T, Luster MI: Impaired cutaneous wound healing in interleukin- 6-deficient and immunosuppressed mice. Faseb J 2000, 14:2525-2531.
6. Ishida Y, Kondo T, Kimura A, Matsushima K, Mukaida N: Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappaB activation and a reciprocal suppression of TGF-beta signal pathway. J Immunol 2006, 176:5598-5606.
7. Mori R, Kondo T, Ohshima T, Ishida Y, Mukaida N: Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. Faseb J 2002, 16:963-974. (Pubitemid 34753502)
8. Ishida Y, Kondo T, Takayasu T, Iwakura Y, Mukaida N, Ishida Y, Kondo T, Takayasu T, Iwakura Y, Mukaida N: The essential involvement of cross-talk between IFN-gamma and TGF-beta in the skin wound-healing process. J Immunol 2004, 172:1848-1855. (Pubitemid 38116834)
9. Eming SA, Werner S, Bugnon P, Wickenhauser C, Siewe L, hlen O, Davidson JM, Krieg T, et al: Accelerated wound closure in mice deficient for interleukin-10. Am J Pathol 2007, 170:188-202. (Pubitemid 47339199)
10. Muller G, Saloga J, Germann T, Bellinghausen I, Mohamadzadeh M, Knop J, Enk AH: Identification and induction of human keratinocyte-derived IL-12. J Clin Invest 1994, 94:1799-1805. (Pubitemid 24348215)
11. Trinchieri G, Pflanz S, Kastelein RA, Trinchieri G, Pflanz S, Kastelein RA: The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003, 19:641-644. (Pubitemid 37490789)
12. Mikols CL, Yan L, Norris JY, Russell TD, Khalifah AP, Hachem RR, Chakinala MM, Yusen RD, Castro M, Kuo E, et al: IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. Am J Respir Crit Care Med 2006, 174:461-470. (Pubitemid 44223128)
13. Saunus JM, Wagner SA, Matias MA, Hu Y, Zaini ZM, Farah CS: Early activation of the interleukin-23-17 axis in a murine model of oropharyngeal candidiasis. Molec Oral Microb 2010, 25:343-356.
14. Voest EE, Kenyon BM, O'Reilly MS, Truitt G, D'Amato RJ, Folkman J: Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 1995, 87:581-586.
15. Meeran SM, Katiyar S, Elmets CA, Katiyar SK, Meeran SM, Katiyar S, Elmets CA, Katiyar SK: Interleukin-12 deficiency is permissive for angiogenesis in UV radiation-induced skin tumors. Cancer Res 2007, 67:3785-3793. (Pubitemid 46762165)
16. Luster AD, Cardiff RD, MacLean JA, Crowe K, Granstein RD: Delayed wound healing and disorganized neovascularization in transgenic mice expressing the IP-10 chemokine. Proc Assoc Am Physicians 1998, 110:183-196. (Pubitemid 28235170)
17. Luster AD, Greenberg SM, Leder P: The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 1995, 182:219-231.
18. Gillessen S, Carvajal D, Ling P, Podlaski FJ, Stremlo DL, Familletti PC, Gubler U, Presky DH, Stern AS, Gately MK: Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol 1995, 25:200-206.
19. Ling P, Gately MK, Gubler U, Stern AS, Lin P, Hollfelder K, Su C, Pan YC, Hakimi J: Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 1995, 154:116-127.
20. Ha SJ, Lee CH, Lee SB, Kim CM, Jang KL, Shin HS, Sung YC: A novel function of IL-12p40 as a chemotactic molecule for macrophages. J Immunol 1999, 163:2902-2908. (Pubitemid 29399221)
21. Khader SA, Partida-Sanchez S, Bell G, Jelley-Gibbs DM, Swain S, Pearl JE, Ghilardi N, Desauvage FJ, Lund FE, Cooper AM, et al: Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J Exp Med 2006, 203:1805-1815. (Pubitemid 44036285)
22. Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K, Basham B, McClanahan T, Kastelein RA, Oft M, et al: IL-23 promotes tumour incidence and growth. Nature 2006, 442:461-465. (Pubitemid 44264796)
23. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA, Gately MK: IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 1996, 4:471-481. (Pubitemid 26354656)
24. Harper EG, Guo C, Rizzo H, Lillis JV, Kurtz SE, Skorcheva I, Purdy D, Fitch E, Iordanov M, Blauvelt A: Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Derm 2009, 129:2175-2183.
25. Low QE, Drugea IA, Duffner LA, Quinn DG, Cook DN, Rollins BJ, Kovacs EJ, DiPietro LA: Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice. Am J Pathol 2001, 159:457-463. (Pubitemid 32751076)
26. Ishida Y, Kondo T, Takayasu T, Iwakura Y, Mukaida N: The essential involvement of cross-talk between IFN-gamma and TGF-beta in the skin wound-healing process. J Immunol 2004, 172:1848-1855. (Pubitemid 38116834)
27. DiPietro LA, Burdick M, Low QE, Kunkel SL, Strieter RM: MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Invest 1998, 101:1693-1698. (Pubitemid 28198499)
28. Frank S, Kampfer H, Wetzler C, Stallmeyer B, Pfeilschifter J: Large induction of the chemotactic cytokine RANTES during cutaneous wound repair: a regulatory role for nitric oxide in keratinocyte-derived RANTES expression. Biochem J 2000, 347 Pt 1:: 265-273. (Pubitemid 30199066)
29. Wetzler C, mpfer H, Stallmeyer B, Pfeilschifter J, Frank S: Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophils and macrophages during the late phase of repair. J Invest Derm 2000, 115:245-253. (Pubitemid 30637194)
30. Gillitzer R: Inflammation in human skin: a model to study chemokine-mediated leukocyte migration in vivo. J Pathol 2001, 194:393-394.
31. Gillitzer R, Goebeler M: Chemokines in cutaneous wound healing. J Leukoc Biol 2001, 69:513-521. (Pubitemid 32294835)
32. Werner S, Grose R: Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003, 83:835-870. (Pubitemid 36828927)
33. Engelhardt E, Toksoy A, Goebeler M, Debus S, Brocker EB, Gillitzer R: Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 1998, 153:1849-1860. (Pubitemid 28550672)
34. Romagnani P, Lasagni L, Annunziato F, Serio M, Romagnani S: CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol 2004, 25:201-209. (Pubitemid 38372168)
35. Grellner W, Georg T, Wilske J: Quantitative analysis of proinflammatory cytokines (IL-1beta, IL-6, TNF-alpha) in human skin wounds. Forensic Sci Int 2000, 113:251-264. (Pubitemid 30649744)
36. Grose R, Harris BS, Cooper L, Topilko P, Martin P: Immediate early genes krox-24 and krox-20 are rapidly up-regulated after wounding in the embryonic and adult mouse. Dev Dyn 2002, 223:371-378. (Pubitemid 34203081)
37. Hubner G, Brauchle M, Smola H, Madlener M, Fassler R, Werner S: Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 1996, 8:548-556. (Pubitemid 26294545)
38. Yebra M, Parry GC, mblad S, Mackman N, Rosenberg S, Mueller BM, Cheresh DA: Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration. J Biol Chem 1996, 271:29393-29399. (Pubitemid 26382657)
39. Suzuma K, Takagi H, Otani A, Honda Y: Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci 1998, 39:1028-1035. (Pubitemid 28196689)
40. Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Peruzzi CA, Detmar M: Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol 1996, 149:293-305. (Pubitemid 26231000)
41. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M: Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996, 270:H411-415.
42. Pepper MS, Ferrara N, Orci L, Montesano R: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992, 189:824-831. (Pubitemid 23032448)
43. Goto F, Goto K, Weindel K, Folkman J: Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993, 69:508-517. (Pubitemid 24004487)
44. Watanabe Y, Lee SW, Detmar M, Ajioka I, Dvorak HF: Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene 1997, 14:2025-2032. (Pubitemid 27237005)
45. Roman CD, Choy H, Nanney L, Riordan C, Parman K, Johnson D, Beauchamp RD: Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats. J Surg Res 2002, 105:43-47. (Pubitemid 34713210)
46. McGrath MH, Emery JM: The effect of inhibition of angiogenesis in granulation tissue on wound healing and the fibroblast. Ann Plast Surg 1985, 15:105-122. (Pubitemid 15247048)
47. Dias S, Boyd R, Balkwill F: IL-12 regulates VEGF and MMPs in a murine breast cancer model. Int J Cancer 1998, 78:361-365. (Pubitemid 28445375)
48. Mitola S, Strasly M, Prato M, Ghia P, Bussolino F: IL-12 regulates an endothelial cell-lymphocyte network: effect on metalloproteinase-9 production. J Immunol 2003, 171:3725-3733. (Pubitemid 37264926)
49. Strasly M, Cavallo F, Geuna M, Mitola S, Colombo MP, Forni G, Bussolino F: IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. J Immunol 2001, 166:3890-3899. (Pubitemid 32224915)
50. Stupack DG, Cheresh DA: ECM remodeling regulates angiogenesis: endothelial integrins look for new ligands. [Review] [69 refs]. Science's Stke [Electronic Resource]: Signal Transduction Knowledge Environment 2002, 2002:PE7.
51. Bergsten E, Uutela M, Li X, Pietras K, Ostman A, Heldin CH, Alitalo K, Eriksson U: PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol 2001, 3:512-516. (Pubitemid 32422089)
52. Hao Q, Su H, Palmer D, Sun B, Gao P, Yang G-Y, Young WL: Bone marrow-derived cells contribute to vascular endothelial growth factor-induced angiogenesis in the adult mouse brain by supplying matrix metalloproteinase-9. Stroke 2011, 42:453-458.
53. Altinova AE, Engin D, Akbay E, Akturk M, Toruner F, Ersoy R, Yetkin I, Arslan M: Association of polymorphisms in the IL-18 and IL-12 genes with susceptibility to Type 1 diabetes in Turkish patients. J Endocrinol Invest 2010, 33:451-454.
54. Morahan G, McKinnon E, Berry J, Browning B, Julier C, Pociot F, James I, Type IDGC: Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium. Genes Immun 2009, 10(Suppl 1):S64-68.
55. Truong W, Hancock WW, Plester JC, Merani S, Rayner DC, Thangavelu G, Murphy KM, Anderson CC, Shapiro AMJ: BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice. J Leukoc Biol 2009, 86:41-51.
56. Duffin KC, Woodcock J, Krueger GG: Genetic variations associated with psoriasis and psoriatic arthritis found by genome-wide association. Dermatol Therapy 2010, 23:101-113.